Amifampridine Phosphate 10 MG Oral Tablet
SMA-002
Phase 2 small_molecule terminated
Quick answer
Amifampridine Phosphate 10 MG Oral Tablet for Spinal Muscular Atrophy Type 3 is a Phase 2 program (small_molecule) at CATALYST PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CATALYST PHARMACEUTICALS, INC.
- Indication
- Spinal Muscular Atrophy Type 3
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated